Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Analyst Ratings
Moderate Buy
11 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ELV Stock 12 Month Forecast
Average Price Target
$384.87
▲(31.97% Upside)
| Highest Price Target$425.00 | Average Price Target$384.87 | Lowest Price Target$332.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Mizuho Securities
$413→$350
Buy
20.02%
Upside
Reiterated
03/11/26
Barclays
$393
Buy
34.76%
Upside
Reiterated
03/11/26
Wells Fargo
$391
Buy
34.07%
Upside
Reiterated
03/03/26
RBC Capital
$392→$358
Hold
22.76%
Upside
Downgraded
02/03/26
Truist Financial
$400→$390
Buy
33.73%
Upside
Reiterated
02/02/26
J.P. Morgan
$394→$397
Buy
36.13%
Upside
Reiterated
02/02/26
TD Cowen
$400
Buy
37.16%
Upside
Reiterated
02/02/26
Bernstein
$431→$409
Buy
40.25%
Upside
Reiterated
02/02/26
Morgan Stanley
$352
Hold
20.70%
Upside
Reiterated
01/29/26
UBS
$425→$400
Buy
37.16%
Upside
Reiterated
01/29/26
Deutsche Bank
$320→$332
Hold
13.84%
Upside
Reiterated
01/29/26
Bank of America Securities
$385
Hold
32.02%
Upside
Reiterated
01/29/26
Guggenheim
$414→$396
Buy
35.79%
Upside
Reiterated
01/28/26
Wolfe Research
$425
Buy
45.73%
Upside
Upgraded
01/07/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
$413→$350
Buy
20.02%
Upside
Reiterated
03/11/26
Barclays
$393
Buy
34.76%
Upside
Reiterated
03/11/26
Wells Fargo
$391
Buy
34.07%
Upside
Reiterated
03/03/26
RBC Capital
$392→$358
Hold
22.76%
Upside
Downgraded
02/03/26
Truist Financial
$400→$390
Buy
33.73%
Upside
Reiterated
02/02/26
J.P. Morgan
$394→$397
Buy
36.13%
Upside
Reiterated
02/02/26
TD Cowen
$400
Buy
37.16%
Upside
Reiterated
02/02/26
Bernstein
$431→$409
Buy
40.25%
Upside
Reiterated
02/02/26
Morgan Stanley
$352
Hold
20.70%
Upside
Reiterated
01/29/26
UBS
$425→$400
Buy
37.16%
Upside
Reiterated
01/29/26
Deutsche Bank
$320→$332
Hold
13.84%
Upside
Reiterated
01/29/26
Bank of America Securities
$385
Hold
32.02%
Upside
Reiterated
01/29/26
Guggenheim
$414→$396
Buy
35.79%
Upside
Reiterated
01/28/26
Wolfe Research
$425
Buy
45.73%
Upside
Upgraded
01/07/26
Best Analysts Covering Elevance Health
3 Months
xxx
Success Rate
10/16 ratings generated profit
Average Return
+2.04%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +2.04% per trade.
1 Year
2 Years
xxx
Success Rate
24/31 ratings generated profit
Average Return
+35.93%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.42% of your transactions generating a profit, with an average return of +35.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ELV Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
41
31
26
28
25
Hold
38
23
29
25
40
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
79
54
55
53
65
Each month's total comprises the sum of three months' worth of ratings.
ELV Financial Forecast
ELV Stock Forecast FAQ
What is ELV’s average 12-month price target, according to analysts?
Based on analyst ratings, Elevance Health’s 12-month average price target is 384.87.
What is ELV’s upside potential, based on the analysts’ average price target?
Elevance Health has 31.97% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ELV a Buy, Sell or Hold?
Elevance Health has a consensus rating of Moderate Buy which is based on 11 buy ratings, 4 hold ratings and 0 sell ratings.
What is Elevance Health’s price target?
The average price target for Elevance Health is 384.87. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $425.00 ,the lowest forecast is $332.00. The average price target represents 31.97% Increase from the current price of $291.63.
The highest analyst price target is $425.00 ,the lowest forecast is $332.00. The average price target represents 31.97% Increase from the current price of $291.63.
What do analysts say about Elevance Health?
Elevance Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of ELV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.